文献速递心力衰竭与心肌病心律失常血脂与心血管预防

心房机械收缩预测转甲状腺素蛋白淀粉样心肌病窦性心律患者的脑血管风险

Atrial Mechanical Contraction Predicts Cerebrovascular Risk in Patients With Transthyretin Amyloid Cardiomyopathy and Sinus Rhythm.
PubMed 文献 · J Am Coll Cardiol · 2026-02-18

该研究基于英国国家淀粉样变性中心2003至2023年诊断的2310例ATTR-CM患者,其中873例窦性心律且未抗凝者纳入分析,用斑点追踪应变超声评估左房功能。结果显示心房电机械分离(AEMD)与房颤发生及卒中/TIA风险升高独立相关,左房应变收缩(LASc)越低风险越高,将LASc三分位加入CHA2DS2-VASc可改善1年风险再分类。

要点

  • 窦性心律ATTR-CM患者中AEMD患病率为13.2%,与卒中/TIA和房颤风险升高独立相关。
  • LASc<4%者1年卒中/TIA风险较LASc>7%者高10倍,独立于NAC分期与既往脑血管事件。
  • 对窦性心律ATTR-CM患者应评估左房应变,以识别可能受益于强化心律监测或预防性抗凝者。

核心结论

  • 左房功能障碍,尤其AEMD与严重受损的LASc,与ATTR-CM患者脑血管事件增加相关。
  • 左房应变分析可优化风险分层,帮助识别窦性心律ATTR-CM中可能受益于强化延长心律监测或预防性抗凝的患者。

研究设计与样本

  • 其中873例为窦性心律且未接受抗凝治疗,年龄77岁,82%男性,61%为野生型,CHA2DS2-VASc评分4分。
  • 左房功能采用斑点追踪应变超声评估,AEMD定义为心电图窦性心律且左房应变收缩缺失。
  • 窦性心律患者按LASc三分位分层,主要终点为卒中或短暂性脑缺血发作(TIA)中首发者,次要终点为房颤发生,死亡作为竞争事件。

主要发现

  • AEMD存在于115例患者(13.2%)。
  • 窦性心律患者中位随访34个月(Q1-Q3:18-54个月)期间,269例(30.8%)发生房颤,85例(9.7%)发生卒中/TIA。
  • 基线房颤且接受抗凝治疗者的卒中或TIA发生率为0.7/100人年。
  • AEMD与房颤发生风险升高2.4倍、卒中或TIA风险升高3倍相关(卒中/TIA分别为8.7 vs 2.5/100人年),独立于CHA2DS2评分及疾病严重度标志物。
  • 758例无AEMD的窦性心律患者中,LASc三分位(<4%、4%-7%、>7%)与1年卒中/TIA风险独立相关,LASc<4%较>7%风险增加10倍,校正NAC分期和既往脑血管事件后一致。

关键数值与推荐

  • AEMD定义为心电图窦性心律且左房应变收缩缺失,在本队列窦性心律未抗凝患者中占13.2%。
  • LASc三分位界值为<4%、4%-7%、>7%,LASc<4%者1年卒中/TIA风险较>7%者高10倍。
  • AEMD者卒中/TIA发生率为8.7/100人年,有左房机械收缩的窦性心律者为2.5/100人年。
  • 基线房颤接受抗凝者卒中或TIA发生率为0.7/100人年。

临床怎么用

  • 对窦性心律ATTR-CM患者可考虑行左房应变超声评估,识别AEMD及LASc严重受损者。
  • 对AEMD或LASc<4%的高危患者,可考虑强化延长心律监测,并个体化评估预防性抗凝的潜在获益。
  • 将LASc三分位纳入CHA2DS2-VASc或CHA2DS2-VA有助于改善1年卒中/TIA风险再分类。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with transthyretin amyloid cardiomyopathy (ATTR-CM) remain at risk of cerebrovascular events even when in sinus rhythm (SR), yet the majority of these patients are unrecognized. OBJECTIVES: This study sought to identify patients in SR at high risk of cerebrovascular events. METHODS: We analyzed patients diagnosed with ATTR-CM between January 2003 and December 2023 at the UK National Amyloidosis Centre. Left atrial (LA) function was assessed using speckle-tracking strain echocardiography. Atrial electromechanical dissociation (AEMD) was defined as SR on electrocardiogram with absent left atrial strain contraction (LASc). Patients in SR were stratified according to LASc tertiles. The primary outcome was a cerebrovascular event defined as stroke or transient ischemic attack (TIA), whichever occurred first. The secondary outcome was development of atrial fibrillation (AF). Death was treated as a competing event. RESULTS: The study comprised 2,310 patients with ATTR-CM, of which 873 patients were in SR and not receiving anticoagulation (age 77 years, 82% male, 61% wild type, CHA2DS2-VASc 4). AEMD was present in 115 patients (13.2%). Of the patients in SR, over a median of 34 months (Q1-Q3: 18-54 months), 269 patients (30.8%) developed incident AF and 85 (9.7%) experienced stroke/TIA. Patients with baseline AF receiving anticoagulation had a rate of stroke or TIA of 0.7 per 100 person-years. AEMD was associated with a 2.4-fold higher incident AF and 3-fold higher risk of stroke or TIA compared with SR with LA mechanical contraction (8.7 vs 2.5 per 100 person-years, respectively, for stroke or TIA), independent of CHA2DS2-based scores and markers of disease severity. Among 758 patients in SR without AEMD, LASc tertiles (<4%, 4%-7%, >7%) exhibited an independent association with 1-year risk of stroke or TIA, with LASc <4% being associated with 10-fold increased risk compared to LASc >7%. This association was consistent after adjustment for NAC stage and prior cerebrovascular events. Adding LASc tertiles to CHA2DS2-VASc or CHA2DS2-VA significantly improved model fit and risk reclassification at 1 year. CONCLUSIONS: LA dysfunction, particularly AEMD and severely impaired LASc, is associated with increased cerebrovascular events in ATTR-CM. Using LAS analysis may refine risk stratification and help identify patients with ATTR-CM in SR who might potentially benefit from intensified extended rhythm monitoring or prophylactic anticoagulation.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Porcari A, Passo BD, Venneri L, et al. Atrial Mechanical Contraction Predicts Cerebrovascular Risk in Patients With Transthyretin Amyloid Cardiomyopathy and Sinus Rhythm. J Am Coll Cardiol. 2026. PMID: 41706061. doi:10.1016/j.jacc.2025.12.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。